-
S649696-50mgSevasemten is an allosteric inhibitor of skeletal muscle myosin. Sevasemten exhibits selectively myosin inhibition with IC 50 s of ≤10 μM (skeletal), >100 μM (cardiac), respectively.Form:Solid
-
S649696-5mgSevasemten is an allosteric inhibitor of skeletal muscle myosin. Sevasemten exhibits selectively myosin inhibition with IC 50 s of ≤10 μM (skeletal), >100 μM (cardiac), respectively.Form:Solid
-
S651472-10mgSibrafiban (RO 48-3657) is the orally active, nonpeptide, double-proagent of Ro 44-3888 and a selective glycoprotein IIb/IIIa receptor antagonist. Sibrafiban inhibits platelet aggregationIn VitroThe effects of site occupancy by Sibrafiban on
-
S651472-25mgSibrafiban (RO 48-3657) is the orally active, nonpeptide, double-proagent of Ro 44-3888 and a selective glycoprotein IIb/IIIa receptor antagonist. Sibrafiban inhibits platelet aggregationIn VitroThe effects of site occupancy by Sibrafiban on
-
S651472-5mgSibrafiban (RO 48-3657) is the orally active, nonpeptide, double-proagent of Ro 44-3888 and a selective glycoprotein IIb/IIIa receptor antagonist. Sibrafiban inhibits platelet aggregationIn VitroThe effects of site occupancy by Sibrafiban on
-
S656691-1mlSibrafiban (RO 48-3657) is the orally active, nonpeptide, double-proagent of Ro 44-3888 and a selective glycoprotein IIb/IIIa receptor antagonist. Sibrafiban inhibits platelet aggregationIn VitroThe effects of site occupancy by Sibrafiban on
-
Z659235-100mgZalunfiban (RUC-4) dihydrochloride is a potent, selective platelet αIIbβ3 antagonist ( IC 50 =45 nM). Zalunfiban dihydrochloride can be used for the research of myocardial infarction (MI).Appearance:SolidIC50& Target:IC50: 45 nM (αIIbβ3)In
-
Z659235-10mgZalunfiban (RUC-4) dihydrochloride is a potent, selective platelet αIIbβ3 antagonist ( IC 50 =45 nM). Zalunfiban dihydrochloride can be used for the research of myocardial infarction (MI).Appearance:SolidIC50& Target:IC50: 45 nM (αIIbβ3)In
-
Z659235-25mgZalunfiban (RUC-4) dihydrochloride is a potent, selective platelet αIIbβ3 antagonist ( IC 50 =45 nM). Zalunfiban dihydrochloride can be used for the research of myocardial infarction (MI).Appearance:SolidIC50& Target:IC50: 45 nM (αIIbβ3)In
-
Z659235-50mgZalunfiban (RUC-4) dihydrochloride is a potent, selective platelet αIIbβ3 antagonist ( IC 50 =45 nM). Zalunfiban dihydrochloride can be used for the research of myocardial infarction (MI).Appearance:SolidIC50& Target:IC50: 45 nM (αIIbβ3)In
-
Z659235-5mgZalunfiban (RUC-4) dihydrochloride is a potent, selective platelet αIIbβ3 antagonist ( IC 50 =45 nM). Zalunfiban dihydrochloride can be used for the research of myocardial infarction (MI).Appearance:SolidIC50& Target:IC50: 45 nM (αIIbβ3)In
-
Z661676-1mlZalunfiban (RUC-4) dihydrochloride is a potent, selective platelet αIIbβ3 antagonist ( IC 50 =45 nM). Zalunfiban dihydrochloride can be used for the research of myocardial infarction (MI).IC50& Target:IC50: 45 nM (αIIbβ3)In Vivo:Zalunfiban